StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “buy” rating on the stock.
Mannatech Trading Down 3.7 %
NASDAQ MTEX opened at $11.44 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The business has a fifty day simple moving average of $8.82 and a 200 day simple moving average of $7.88. Mannatech has a 12 month low of $6.75 and a 12 month high of $13.00. The firm has a market capitalization of $21.56 million, a P/E ratio of -14.12 and a beta of 1.18.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The firm had revenue of $31.73 million during the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- There Are Different Types of Stock To Invest In
- Micron Stock Under $100: Seize the AI-Driven Upside
- How to Use the MarketBeat Excel Dividend Calculator
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Energy and Oil Stocks Explained
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
